If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPressure Tech Regulatory News (PRES)

  • There is currently no data for PRES

Exercise of Options

16 Feb 2017 12:42

RNS Number : 0960X
Pressure Technologies PLC
16 February 2017
 

16 February 2017

 

Pressure Technologies plc

("Pressure Technologies" or the "Company")

 

Exercise of Options

 

Pressure Technologies plc announces that it has issued and allotted 3,461 new ordinary shares of 5p each in the Company, following an exercise of options pursuant to the Company's SAYE scheme. The options were exercised at a price of 156 pence per share.

 

The new ordinary shares will rank pari passu with existing ordinary shares in the Company and application has been made for these new ordinary shares to be admitted to trading on AIM, which is expected to occur on or around 24 February 2017.

 

Total Voting Rights

 

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of ordinary shares of 5 pence of Pressure Technologies in issue at the date of this notice is 14,482,670.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in Pressure Technologies, under the Disclosure and Transparency Rules.

For further information, please contact:

 

Pressure Technologies plc

Keeley Clarke, Investor Relations

 

Tel: 0114 257 3622

www.pressuretechnologies.com

Cantor Fitzgerald Europe

(Nominated Adviser and Broker)

Tel: 020 7894 7000

Philip Davies / Will Goode

 

COMPANY DESCRIPTION

 

Company description - www.pressuretechnologies.com

 

With its head office in Sheffield, Pressure Technologies was founded on its leading market position as a designer and manufacturer of high-pressure systems serving the global energy, defence and industrial gases markets. Today it continues to serve those markets from a broader engineering base with specialist precision engineering businesses and has a worldwide presence in Alternative Energy as a global leader in biogas upgrading. On this foundation, the company is building a highly profitable group of companies through a combination of organic initiatives and acquisitions.

 

Pressure Technologies has four divisions, Precision Machined Components, Engineered Products, Cylinders and Alternative Energy, serving four markets: oil and gas, defence, industrial gases and alternative energy.

 

Precision Machined Components

· Al-Met, Mid Glamorgan, acquired in 2010 www.almet.co.uk

· Roota Engineering, Rotherham, acquired in March 2014 www.roota.co.uk

· Quadscot, Glasgow, acquired in October 2014 www.quadscot.co.uk

· Martract Limited, Barton-on-Humber, acquired in December 2016 www.martract.co.uk

 

Engineered Products

· Hydratron, Manchester, acquired in 2010 www.hydratron.com

 

Cylinders

· Chesterfield Special Cylinders, Sheffield, IPO cornerstone in 2007 www.chesterfieldcylinders.com

· Kelley GTM Manufacturing, Amarillo, USA - 40% stake acquired by the Group in December 2013 www.kelleygtm.com

 

Alternative Energy

· Greenlane Biogas, Sheffield, UK; Vancouver, Canada and; Auckland, New Zealand acquired in October 2014 www.greenlanebiogas.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEEAAAKFLFXEFF
Date   Source Headline
13th Jan 20203:36 pmRNSOutcome of Sentencing Hearing
17th Dec 20197:00 amRNSPreliminary Results
5th Dec 20197:00 amRNSPostponement of Sentencing
27th Nov 20197:00 amRNSTrial Verdict
21st Nov 20197:00 amRNSNotice of Results and Trading Update
18th Nov 20197:00 amRNSCommencement of Trial
9th Oct 20197:00 amRNSMajor Contract Win with EDF Energy
25th Jun 20197:00 amRNS2019 Interim Results
7th Jun 20197:00 amRNSNew Adviser Appointments and Interim Results date
6th Jun 20194:30 pmRNSDirectorate Change
4th Jun 20197:00 amRNSCompletion of the sale of Greenlane Biogas
28th May 20197:00 amRNSUpdate on the proposed sale of Greenlane Biogas
13th May 201912:31 pmRNSDevelopment in the proposed sale of Greenlane
30th Apr 20193:22 pmRNSHolding(s) in Company
1st Apr 20197:25 amRNSUpdate on the proposed sale of Greenlane Biogas
27th Mar 20196:20 pmRNSHolding(s) in Company
26th Mar 20195:43 pmRNSHolding(s) in Company
26th Mar 20197:00 amRNSHolding(s) in Company
6th Mar 201911:53 amRNSUpdate on HSE Case - Not Guilty Plea Submitted
28th Feb 20195:14 pmRNSHolding(s) in Company
12th Feb 201912:15 pmRNSResult of AGM
8th Feb 201911:40 amRNSUpdate on Health & Safety Executive Investigation
1st Feb 20197:00 amRNSUpdate on the proposed sale of Greenlane Biogas
16th Jan 20198:00 amRNSPublication of Annual Report and Notice of AGM
11th Dec 20187:00 amRNSFinal Results
10th Dec 20187:00 amRNSProposed sale of Greenlane Biogas
8th Oct 20183:54 pmRNSHolding(s) in Company
4th Sep 20187:00 amRNSDirector/PDMR Shareholding
20th Aug 20184:28 pmRNSPurchase of shares by a Director
17th Aug 20187:00 amRNSDirector/PDMR Shareholding
9th Aug 201812:23 pmRNSHolding(s) in Company
31st Jul 201811:45 amRNSDirector/PDMR Shareholding
31st Jul 20187:00 amRNSBoard Changes
27th Jul 20187:30 amRNSGrant of Share Options
24th Jul 201812:06 pmRNSHolding(s) in Company
3rd Jul 20184:48 pmRNSPurchase of shares by Directors
12th Jun 20187:00 amRNS2018 Interim Results
7th Jun 20184:45 pmRNSSale of Hydratron Limited
30th May 20187:00 amRNSTrading Update
16th Apr 201812:02 pmRNSHolding(s) in Company
13th Feb 20181:05 pmRNSResult of AGM
8th Feb 20187:00 amRNSDirectorate Change
8th Jan 20183:12 pmRNSPublication of Annual Report and Notice of AGM
12th Dec 201711:05 amRNSSecond Price Monitoring Extn
12th Dec 201711:00 amRNSPrice Monitoring Extension
12th Dec 20177:00 amRNSFinal Results
7th Nov 20174:30 pmRNSDirectors Shareholdings
7th Nov 20171:01 pmRNSHolding(s) in Company
3rd Nov 201712:31 pmRNSResult of General Meeting
16th Oct 20174:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.